VEXAS research hub

A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)

This study is testing a new drug, pacritinib, for VEXAS syndrome. Researchers want to see if it's safe and helps reduce flare-ups and the need for steroids in people aged 18 and over with VEXAS.